Skip to main content
Top

Experimental Hematology & Oncology

Issue 1/2015

Content (34 Articles)

New frontiers for platelet CD154

  • Open Access
  • Review

Antoine Dewitte, Annabelle Tanga, Julien Villeneuve, Sébastien Lepreux, Alexandre Ouattara, Alexis Desmoulière, Christian Combe, Jean Ripoche

Selective inhibitors of nuclear export (SINE) in hematological malignancies

  • Open Access
  • Review

Arundhati Das, Guoqing Wei, Kaushal Parikh, Delong Liu

Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia

  • Open Access
  • Case report

Heidys Garrote, Adolfo de la Fuente, Raquel Oña, Inmaculada Rodríguez, Juan E Echevarría, Juan M Sepúlveda, Juan F García

CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma

  • Open Access
  • Research

Seong-Su Han, Van S Tompkins, Dong-Ju Son, Sangwoo Han, Hwakyung Yun, Natalie L Kamberos, Casey L Dehoedt, Chunyan Gu, Carol Holman, Guido Tricot, Fenghuang Zhan, Siegfried Janz

Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis

  • Open Access
  • Research

Georg Hess, Bertrand Coiffier, Michael Crump, Christian Gisselbrecht, Fritz Offner, Jorge Romaguera, Lisa Kang, Pádraig J Moran

Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1

  • Open Access
  • Research

Shiho Fujiwara, Naoko Wada, Yawara Kawano, Yutaka Okuno, Yoshitaka Kikukawa, Shinya Endo, Nao Nishimura, Nina Ueno, Hiroaki Mitsuya, Hiroyuki Hata

Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models

  • Open Access
  • Research

Joseph Delano Robles, Yin Ping Liu, Jiamin Cao, Zheng Xiang, Yin Cai, Michael Manio, Eva HC Tang, Godfrey Chi-Fung Chan

Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia

  • Open Access
  • Research

Yajuan Cui, Hongyan Tong, Xin Du, Bing Li, Robert Peter Gale, Tiejun Qin, Jinqin Liu, Zefeng Xu, Yue Zhang, Gang Huang, Jie Jin, Liwei Fang, Hongli Zhang, Lijuan Pan, Naibo Hu, Shiqiang Qu, Zhijian Xiao

Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies

  • Open Access
  • Research

Marita C. Lynagh, Tara Clinton-McHarg, Alix Hall, Rob Sanson-Fisher, William Stevenson, Campbell Tiley, Alessandra Bisquera

Proteomic analysis of HEK293 cells expressing non small cell lung carcinoma associated epidermal growth factor receptor variants reveals induction of heat shock response

  • Open Access
  • Letter to the Editor

Arpana Kamath, Ann M Joseph, Kumud Gupta, Digamber Behera, Anand Jaiswal, Ravindra Dewan, Maitreyi S Rajala

Long term efficacy and safety of Fludarabine, Cyclophosphamide and Rituximab regimen followed by 90Y-ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma

  • Open Access
  • Research

Francesco Pisani, Rosa Sciuto, Maria Laura Dessanti, Diana Giannarelli, Ramy Kayal, Sandra Rea, Francesco Marchesi, Mirella Marino

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

  • Open Access
  • Short report

Magalie P. Tardy, Lauris Gastaud, Mario Ojeda-Uribe, Annick Boscagli, Salvatore Caruso, Richard Skaf, Jean Gutnecht, Antoine Thyss, Frédéric Peyrade

Melanoma tumor growth is accelerated in a mouse model of sickle cell disease

  • Open Access
  • Research

Jintao Wang, Jennifer Tran, Hui Wang, Wei Luo, Chiao Guo, David Harro, Andrew D. Campbell, Daniel T. Eitzman

Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma

  • Open Access
  • Research

Ruth-Miriam Koerber, Stefanie Andrea Erika Held, Annkristin Heine, Philipp Kotthoff, Solveig Nora Daecke, Anita Bringmann, Peter Brossart

Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study

  • Open Access
  • Research

Christina Dicke, Ali Amirkhosravi, Brigitte Spath, Miguel Jiménez-Alcázar, Tobias Fuchs, Monica Davila, John L Francis, Carsten Bokemeyer, Florian Langer

Effect of IKZF1 deletions on signal transduction pathways in Philadelphia chromosome negative pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

  • Open Access
  • Research

Naomi E van der Sligte, Frank J G Scherpen, Arja ter Elst, Victor Guryev, Frank N van Leeuwen, Eveline S J M de Bont

Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma

  • Open Access
  • Case report

Enrico Derenzini, Ilaria Iacobucci, Claudio Agostinelli, Enrica Imbrogno, Clelia Tiziana Storlazzi, Alberto L`Abbate, Beatrice Casadei, Anna Ferrari, Andrea Ghelli Luserna Di Rora`, Giovanni Martinelli, Stefano Pileri, Pier Luigi Zinzani

Novel antidotes for target specific oral anticoagulants

  • Open Access
  • Review

Arundhati Das, Delong Liu

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis

  • Open Access
  • Research

Mary Frances McMullin, Claire N. Harrison, Dietger Niederwieser, Hilde Demuynck, Nadja Jäkel, Prashanth Gopalakrishna, Mari McQuitty, Viktoriya Stalbovskaya, Christian Recher, Koen Theunissen, Heinz Gisslinger, Jean-Jacques Kiladjian, Haifa-Kathrin Al-Ali

CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma

  • Open Access
  • Short report

Ahmad Sattarzadeh, Arjan Diepstra, Bea Rutgers, Anke van den Berg, Lydia Visser

GATA family transcriptional factors: emerging suspects in hematologic disorders

  • Open Access
  • Review

Juehua Gao, Yi-Hua Chen, LoAnn C. Peterson

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing

  • Open Access
  • Case report

Diana Mandelker, Paola Dal Cin, Heather A. Jacene, Philippe Armand, Richard M. Stone, Neal I. Lindeman

Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

  • Open Access
  • Research

Jipan Xie, Yanni Hao, Nanxin Li, Peggy L. Lin, Erika Ohashi, Valerie Koo, Eric Q. Wu

The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

  • Open Access
  • Research

Ying Wang, Zenghui Xu, Fuping Zhou, Yan Sun, Jingbo Chen, Linfang Li, Huajun Jin, Qijun Qian

Breast cancer brain metastases: the last frontier

  • Open Access
  • Review

José Pablo Leone, Bernardo Amadeo Leone

Breast adenocarcinoma recurring as small cell carcinoma in a patient with a germline BRCA2 mutation: clonal evolution unchecked

  • Open Access
  • Case report

Polly Niravath, Tanya Eble, Alejandro Contreras, Marilyn Li, Luis M Franco, Mothaffar Rimawi

Successful treatment of a Caucasian case of multifocal Castleman’s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report

  • Open Access
  • Case report

Silvia Tedesco, Laura Postacchini, Lucia Manfredi, Gaia Goteri, Michele M Luchetti, Antonella Festa, Armando Gabrielli, Giovanni Pomponio

Distinct genetic alterations in small cell carcinoma from different anatomic sites

  • Open Access
  • Review

Xiaoyong Zheng, Delong Liu, John T Fallon, Minghao Zhong

The effect of caffeine on cisplatin-induced apoptosis of lung cancer cells

  • Open Access
  • Research

Gan Wang, Vanitha Bhoopalan, David Wang, Le Wang, Xiaoxin Xu

Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo

  • Open Access
  • Rapid communication

Jesper Kofoed Damm, Sandra Gordon, Mats Ehinger, Mats Jerkeman, Urban Gullberg, Anne Hultquist, Kristina Drott

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now
Video